Medical Coding Updates
The American Medical Association (AMA) has developed and released new monkeypox CPT codes from the regular schedule to address a public health concern and track and report monkeypox testing and vaccinations.
The Centers for Medicare & Medicaid Services (CMS) has released its annual proposed Medicare payment rates for hospital outpatient and Ambulatory Surgical Center (ASC) services. There will be a 60-day comment period for the 2023 OPPS proposed rule.
Monkeypox is coded in the first chapter of ICD-10-CM, Certain infectious and parasitic diseases, and the code is B04. Read further for a summary of the symptoms, transmission, treatments and vaccinations for this rare viral disease.
January 2021 brought significant changes to the Evaluation and Management (E/M) codes for Office and Other Outpatient Services. AMA released a detailed document describing the 2023 E/M changes that will take effect on January 1.
CMS released the FY 2023 ICD-10-PCS codes and guidelines, effective on October 1, 2022. The update summary notes that there are 331 new and 64 deleted codes, totaling 78,496 ICD-10-PCS codes for 2023.
CMS has released the 2023 ICD-10-CM codes and guidelines. The 2023 ICD-10-CM codes are to be used for discharges and patient encounters from October 1, 2022, through September 30, 2023.
CMS has expanded its Medicaid and Children’s Health Insurance Program (CHIP) coverage for postpartum care from 60 days to 12 months in California, Florida, Kentucky, and Oregon.
Several recent lawsuits have brought to light a list of risk adjustment schemes to increase reimbursements in violation of the False Claims Act. Here are some HCC coding 101 best practices to help your organization avoid scrutiny.
What is HCC coding used for? Why is HCC coding important? This brief article will touch on the questions above and explore how a recent YES HCC consulting case study highlights the importance of HCC coding in healthcare.
Three new COVID booster vaccine CPT codes have been released by the AMA: one vaccine product code and two administration codes. The booster candidates are from products developed by Pfizer and Sanofi-GlaxoSmithKline.